Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy-Reference-Cited by-同舟云学术

Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy

Published:2003-10 Issue:10 Volume:14 Page:1589-1590
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Berruti A.,Saini A.,Gorzegno G.,Tampellini M.,Borasio P.,Dogliotti L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/10/1589/420268/mdg420.pdf

Reference5 articles.

1. Second line chemotherapy in patients with relapsed extragonadal germ cell tumors: results of an international multicenter analysis;Hartman;J Clin Oncol,2001

2. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer;Bokemeyer;Ann Oncol,1996

3. Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors;Amato;Urol Oncol,2000

4. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group;Hilton;J Clin Oncol,2002

5. Late relapse of testicular cancer;Baniel;J Clin Oncol,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors;Annals of Oncology;2015-10

2. Third-Line Chemotherapy and Novel Agents for Metastatic Germ Cell Tumors;Hematology/Oncology Clinics of North America;2011-06

3. Can a Cure Be Achieved with Taxane-Based Chemotherapy plus Surgery in Patients with Primary Mediastinal Non-Seminomatous Germ Cell Tumors and Progression or Relapse Despite First-Line Chemotherapy?;Onkologie;2010

4. Successful treatment of disseminated extragonadal germ cell cancer with intensive conventional chemotherapy after first-line high-dose chemotherapy;International Journal of Clinical Oncology;2006-02-28